Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

Clinical trial NCT04915183 · RECRUITING

Trial details

NCT number: NCT04915183
Sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hearing Loss Head and Neck Cancer

Start date: 2024-07-10
Primary completion: 2028-08-01
Enrollment: 224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.